News | October 27, 2021
Cipla consolidated net profit at Rs 711.36 cr. in Q2FY22
Cipla has reported consolidated financial results for the period ended September 30, 2021
Cipla has reported consolidated financial results for the period ended September 30, 2021
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
Support from DFC will help produce one billion vaccine doses by the end of 2022
Through the mission an entire ecosystem for services from treatment to critical research will be created in every corner of the country
Expands wound care portfolio and aims to drive greater market penetration and availability in the wound dressing category
A total of Rs 17,691.08 cr. invested in 157 new approved medical colleges since 2014
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
Fujifilm India recently introduced a “Covid-19 Pneumonia Image Analysis Program” that helps in diagnosing chest CT images that helps in findings of Covid-19 pneumonia
The division is expected to grow to over a 100-member strong team by 2022
Subscribe To Our Newsletter & Stay Updated
